Joseph S. Zakrzewski, Director at ACCELERON PHARMA INC (XLRN), sold 18,196 shares at $135.67 ($2.4M) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Open-market sale of $2.4M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.61 | 104 | $14K | 0.6% |
| 2 | $134.27 | 6,596 | $886K | 36.2% |
| 3 | $134.27 | 6,596 | $886K | 36.2% |
| 4 | $135.22 | 1,700 | $230K | 9.4% |
| 5 | $135.67 | 1,600 | $217K | 8.9% |
| 6 | $135.67 | 1,600 |
| $217K |
| 8.9% |
| Total | $134.60 avg | 18,196 | $2.4M | 100% |
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |